QuiaPEG

About

 
The company
Business model
Management
Board of directors
Intellectual property

The company 

Founded in 2012 in Uppsala, Sweden and listed on Spotlight Stock Market in Stockholm, Sweden, since 2017. QuiaPEG focuses on research, development and commercialization of its proprietary releasable drug-delivery platform Uni-Qleaver®.

 

Contact
QuiaPEG Pharmaceuticals Holding AB

Virdings Allé 32 B
754 50 Uppsala
Sweden
+46 (0) 70 693 12 53
info@quiapeg.com

User terms & privacy policy
Send a message